Literature DB >> 932210

Phosphaturic effect of dopamine in dogs. Possible role of intrarenally produced dopamine in phosphate regulation.

J L Cuche, G R Marchand, R F Greger, R C Lang, F G Knox.   

Abstract

A possible role for dopamine in phosphate handling by the dog kidney was investigated by intrarenal artery infusions of dopamine. Dopamine increased fractional phosphate excretion both in the presence and absence of control of parathyroid hormone and calcitonin. In addition, dopamine increased both renal blood flow and sodium excretion, however, the phosphaturia was independent of these changes; since 30 min after completion of dopamine infusion, renal blood flow and sodium excretion returned to control levels and phosphate excretion remained elevated. For comparison, the vasodilator isoproterenol increased renal blood flow and sodium excretion without a significant change in fractional phosphate excretion. Thus, the phosphaturic effect of dopamine is probably independent of its vasodilator effect. The phosphaturic effect of dopamine could not be accounted for by subsequent conversion to norepinephrine, since norepinephrine was antiphosphaturic in the dog. The effect of endogenous dopamine on renal phosphate excretion was investigated by intrarenal infusion of the precursor dopa. Dopa was phosphaturic both in the presence and absence of parathyroid hormone and calcitonin. In dogs pretreated with carbidopa, which blocks conversion of dopa to dopamine, dopa was no longer phosphaturic, although the kidney remained responsive to dopamine. It is postulated that dopamine may play a role in the intrarenal regulation of phosphate excretion.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 932210      PMCID: PMC333156          DOI: 10.1172/JCI108461

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  EFFECTS OF CATECHOLAMINES ON URINARY CALCIUM AND PHOSPHORUS IN INTACT AND PARATHYROIDECTOMIZED RATS.

Authors:  E R MOREY; A D KENNY
Journal:  Endocrinology       Date:  1964-07       Impact factor: 4.736

2.  DETERMINATION OF 3-HYDROXYTYRAMINE AND DOPA IN VARIOUS ORGANS OF DOG AFTER DOPA-INFUSION.

Authors:  A WEGMANN
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1963-11-08

3.  EVIDENCE FOR A ROLE OF DOPAMINE IN EXTRAPYRAMIDAL FUNCTIONS.

Authors:  A CARLSSON
Journal:  Acta Neuroveg (Wien)       Date:  1964-10-02

4.  The action of antidecarboxylases on the conversion of 3,4-dihydroxyphenylalanine to dopamine in vivo.

Authors:  G F MURPHY; T L SOURKES
Journal:  Arch Biochem Biophys       Date:  1961-05       Impact factor: 4.013

5.  A method for the determination of some amino acid decarboxylases.

Authors:  V E DAVIS; J AWAPARA
Journal:  J Biol Chem       Date:  1960-01       Impact factor: 5.157

6.  The decarboxylation of amino acids related to tyrosine and their awakening action in reserpine-treated mice.

Authors:  H BLASCHKO; T L CHRUSCIEL
Journal:  J Physiol       Date:  1960-05       Impact factor: 5.182

7.  [A simple colorimetric method of inulin determination in renal clearance studies on metabolically normal subjects and diabetics].

Authors:  J FUHR; J KACZMARCZYK; C D KRUTTGEN
Journal:  Klin Wochenschr       Date:  1955-08-01

8.  Aromatic L-amino acid decarboxylase.

Authors:  W LOVENBERG; H WEISSBACH; S UDENFRIEND
Journal:  J Biol Chem       Date:  1962-01       Impact factor: 5.157

9.  The cardiovascular pharmacology of L(--)-dopa: peripheral and central effects.

Authors:  M W Osborne; J J Wenger; W Willems
Journal:  J Pharmacol Exp Ther       Date:  1971-09       Impact factor: 4.030

10.  Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.

Authors:  A M Watanabe; L C Parks; I J Kopin
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

View more
  8 in total

1.  Effect of protein ingestion on urinary dopamine excretion. Evidence for the functional importance of renal decarboxylation of circulating 3,4-dihydroxyphenylalanine in man.

Authors:  M Williams; J B Young; R M Rosa; S Gunn; F H Epstein; L Landsberg
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

2.  Dopaminergic inhibition of vasopressin-stimulated water flow in the toad bladder: evidence for local formation of dopamine.

Authors:  J A Arruda; S Sabatini
Journal:  J Membr Biol       Date:  1982       Impact factor: 1.843

3.  Acute Adaption to Oral or Intravenous Phosphate Requires Parathyroid Hormone.

Authors:  Linto Thomas; Carla Bettoni; Thomas Knöpfel; Nati Hernando; Jürg Biber; Carsten A Wagner
Journal:  J Am Soc Nephrol       Date:  2016-10-06       Impact factor: 10.121

4.  Locally formed 5-hydroxytryptamine stimulates phosphate transport in cultured opossum kidney cells and in rat kidney.

Authors:  Z Hafdi; S Couette; E Comoy; D Prie; C Amiel; G Friedlander
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

5.  Renalase regulates renal dopamine and phosphate metabolism.

Authors:  Daria Sizova; Heino Velazquez; Benedita Sampaio-Maia; Janete Quelhas-Santos; Manuel Pestana; Gary V Desir
Journal:  Am J Physiol Renal Physiol       Date:  2013-07-17

6.  Locally formed dopamine modulates renal Na-Pi co-transport through DA1 and DA2 receptors.

Authors:  R Perrichot; A Garcia-Ocaña; S Couette; E Comoy; C Amiel; G Friedlander
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

7.  Dopamine reduces cell surface Na+/H+ exchanger-3 protein by decreasing NHE3 exocytosis and cell membrane recycling.

Authors:  Ming Chang Hu; I Alexandru Bobulescu; Henry Quiñones; Serge M Gisler; Orson W Moe
Journal:  Am J Physiol Renal Physiol       Date:  2017-08-02

8.  Activation of dopamine D1-like receptors induces acute internalization of the renal Na+/phosphate cotransporter NaPi-IIa in mouse kidney and OK cells.

Authors:  Desa Bacic; Paola Capuano; Michel Baum; Jianning Zhang; Gerti Stange; Jürg Biber; Brigitte Kaissling; Orson W Moe; Carsten A Wagner; Heini Murer
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.